doi: 10.1038/nrendo.2016.86
The SURMOUNT-1 trial demonstrated significant weight loss, with patients losing approximately 15-21% of their body weight at the 15 mg dose over 72 weeks, depending on the statistical method used
These examples assume a target of approximately 1,2001,500 calories daily for women and 1,500-1,800 calories daily for men, with emphasis on protein adequacy
At MedBridge, Tirzepatide is offered as part of a comprehensive weight management program, which combines medical supervision with nutrition guidance, lifestyle coaching , and behavioral support
If you feel unusually tired after starting a GLP-1 medication, the answer is not always your thyroid is off. It could be the drug itself, reduced calorie intake, dehydration, or a real thyroid dose mismatch
[1] [3] This medication works by enhancing insulin secretion in response to meals, suppressing glucagon release, slowing gastric emptying, and reducing appetite through central nervous system pathways